MediLexicon Logo
MediLexicon Logo
Abbreviations        Abbrev Definitions        Dictionary        ICD Codes        Equipment        Hospitals        Drugs        More..
  
ENT and otolaryngology image

ENT Drugs (Ear, Nose and Throat)

Prescription drugs and medicines for conditions relating to ENT (ears, nose, and throat). Otolaryngology is the study of diseases involving the ears and the larynx (organ that helps produce vocal sounds and serves as an air passageway, located in the neck/throat). Studies in this area include: allergy, ear infections, pneumonia, rhinitis, sinus infections, strep throat, and others.

The list of FDA approved drugs for ENT and otolaryngology appears below. Click any link to view the full drug information.


Bookmark and Share
Number Of ENT Drugs (Ear, Nose and Throat): 20

Astepro (azelastine hydrochloride nasal spray)
For the treatment of seasonal and perennial allergic rhinitis
Cedax (ceftibuten)
Treatment for chronic bronchitis, acute bacterial otitis media, pharyngitis/tonsillitis
Depakote ER (divalproex sodium)
For the prophylaxis (prevention) of migraine headaches in adults
Dymista (azelastine hydrochloride and fluticasone propionate)
For the relief of symptoms of seasonal allergic rhinitis
Ethyol (amifostine)
Treatment for xerostomia (dry mouth) due to radiation
Floxin otic
Treatment for otitis media
Moxatag (amoxicillin)
For the treatment of tonsillitis and/or pharyngitis secondary to Streptococcus pyogenes in adults and pediatrics
Omnicef
Treatment against various bacterias
Oravig (miconazole)
oropharyngeal candidiasis
Patanase (olopatadine hydrochloride)
For the treatment of seasonal allergic rhinitis
Protonix (pantoprazole sodium) Delayed-Release Tablets
For treatment of erosive esophagitis
Qnasl (beclomethasone dipropionate) nasal aerosol
For the treatment of seasonal and perennial allergic rhinitis
Rocephin
Treatment for acute otitis media
Rocephin
Treatment for pediatric otitis media
Synercid I.V.
quinupristin and dalfopristin for injection
Tri-Nasal Spray (triamcinolone acetonide spray)
For treatment of nasal symptoms of allergic rhinitis in adults and children age 12 or older
Vandetanib (vandetanib)
For the treatment of thyroid cancer
Veramyst (fluticasone furoate)
For the treatment of seasonal and perennial allergic rhinitis
Xyzal (levocetirizine dihydrochloride)
For the treatment of seasonal and perennial allergic rhinitis and urticaria


« back to top
FDA Approved ENT Drugs (Ear, Nose and Throat) Listings:

The rules of principle for evaluating MediLexicon's FDA ent drugs (ear, nose and throat) listings adhere to the FDA definitions of a new drug approval or a new molecular entity, and the Tufts Center for the Study of Drug Development.

MediLexicon's FDA Approved Drugs Listings include:

New Molecular Entities (NME): these NME's are described as a medication containing an active substance that have never previously approved in the US for marketing in any manner, shape or form (as defined by the FDA). In addition to this, there is also the inclusion of some FDA's Center for Drug Evaluation and Research (CDER) approved recombinant proteins and biologics.

MediLexicon's FDA Approved Drugs Listings do NOT include:

Over-the-counter products, diagnostic agents, generics, most vaccines, medical devices, biologic compounds (not approved by CDER), as well as new indications and new administrations of previously-approved compounds and new dosages.

The ent drugs (ear, nose and throat) information used in this section is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.






MediLexicon International Ltd Logo

Privacy Policy   |    Disclaimer   |    Contact / Feedback

MediLexicon International Ltd
Bexhill-on-Sea, UK
MediLexicon International Ltd © 2004-2014 All rights reserved.